China-Administration of Nicorandil Group（CHANGE）

NCT03445728 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

238

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction
Percutaneous Coronary Intervention
Nicorandil

Interventions

DRUG: Nicorandil
OTHER: Placebo

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]